Introduction: Shenzhen Shankang Medical and Health Industry Co., Ltd. is a medical and health industry company invested by many fund companies such as Shenzhen Yuancheng Fuhai Emerging Industry Investment Enterprise. Mainly engaged in the research and development of long-term sustained and controlled release drugs, mastering the core technology of sustained and controlled release implantable dosage forms, and is currently at the international leading level. The long-acting drug naltrexone implant developed by our company has entered the phase II and III clinical trials of CFDA and will be listed soon. The company is registered on 20 17 and 10. The predecessor of the company has more than ten years of research and development foundation of drug sustained release technology, and successfully completed the pre-clinical research and phase I clinical trial of naltrexone implant. The newly established Shenzhen Shankang Medical and Health Industry Co., Ltd. is to industrialize its products in Shenzhen and establish a first-class sustained and controlled release drug research and development platform, which will have

Legal Representative: Zhang Tao.

Established: 20 17- 10-24.

Registered capital: 65,438 yuan+02.5 million yuan.

Industrial and commercial registration number: 4403002027 14409

Enterprise type: limited liability company

Company address: Building A 1 F, Lien Chan Science and Technology Electronics Factory, Pingshan Street, Pingshan District, Shenzhen